|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Toxicology Monitoring Carisoprodol Metabolite, Quantitative, Urine
Test Code91543
CPT Codes
80369 (HCPCS: G0480)<br>Restricted Client Code
Preferred Specimen
3 mL urine submitted in clinical drug test transport vial
Minimum Volume
2 mL
Other Acceptable Specimens
Urine collected in urine collection container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved samples
Methodology
Mass Spectrometry (MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 3 days
Reference Range
<1000 ng/mL
Clinical Significance
The management of patients? use of controlled substances is an increasing focus of law enforcement to ensure that prescribed medications aren?t diverted and is critical to the successful outcome of many pharmaco-therapies. Urine drug testing for the presence or absence of prescribed medications and illicit drugs is a strategy designed to help the treating physician monitor their patients for compliance with that physician?s directive(s).
